Sorry to resurrect this thread guys – but perhaps one of the more knowledable posters can help an interested observer of EMS.
Reading through the Londonpharma website theres no mention of EMS (as has been pointed out) – but also it conveys the impression that what is being tested in the trial is their special patented sublingual spray delivery system.
Lets assume positive trial results – Londonpharma says – our system works and if EMS wants it lets negotiate a deal and then we go off together to sell the package.
Or does EMS say ArTiMist works and that’s ours and we don’t need any special patented delivery system - and off it goes and sells it product.
Im obviously confused?
- Forums
- ASX - By Stock
- EMS
- london pharma website re artimist
london pharma website re artimist, page-11
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)